Siemens Healthineers AG (OTCMKTS:SMMNY) Receives Average Rating of “Buy” from Analysts

Siemens Healthineers AG (OTCMKTS:SMMNY) has received an average recommendation of “Buy” from the seven brokerages that are currently covering the firm, MarketBeat Ratings reports. Two analysts have rated the stock with a hold recommendation, two have issued a buy recommendation and three have given a strong buy recommendation to the company.

SMMNY has been the subject of a number of research reports. Sanford C. Bernstein raised Siemens Healthineers to a “strong-buy” rating in a research note on Tuesday, January 13th. Zacks Research raised Siemens Healthineers from a “strong sell” rating to a “hold” rating in a research note on Monday, January 12th. Royal Bank Of Canada began coverage on Siemens Healthineers in a research note on Wednesday, December 17th. They set a “moderate buy” rating for the company. Citigroup reissued a “buy” rating on shares of Siemens Healthineers in a report on Friday, January 23rd. Finally, Deutsche Bank Aktiengesellschaft lowered shares of Siemens Healthineers from a “buy” rating to a “hold” rating in a research report on Thursday, December 4th.

Siemens Healthineers Stock Down 1.9%

Siemens Healthineers stock opened at $20.44 on Thursday. The company has a fifty day moving average price of $23.86 and a two-hundred day moving average price of $25.62. Siemens Healthineers has a 12 month low of $20.44 and a 12 month high of $28.92.

Siemens Healthineers Company Profile

Siemens Healthineers AG is a leading global medical technology company that develops, manufactures and distributes a broad range of products and services for the healthcare sector. Headquartered in Erlangen, Germany, the company focuses on diagnostic and therapeutic imaging, in vitro diagnostics and advanced digital health solutions. As a spin-off from Siemens AG, Siemens Healthineers has leveraged decades of engineering expertise to establish a comprehensive portfolio that addresses critical needs in modern healthcare.

The company’s core offerings include magnetic resonance imaging (MRI), computed tomography (CT), X-ray and molecular imaging systems, as well as laboratory diagnostics equipment and point-of-care testing devices.